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Objective: Atonic postpartum hemorrhage rates have increased in
many industrialized countries in recent years. We examined the
blood loss, risk factors, and management of the third stage of labour
associated with atonic postpartum hemorrhage.
Methods: We carried out a case-control study of patients in eight
tertiary care hospitals in Canada between January 2011 and
December 2013. Cases were deﬁned as women with a diagnosis of
atonic postpartum hemorrhage, and controls (without postpartum
hemorrhage) were matched with cases by hospital and date of
delivery. Estimated blood loss, risk factors, and management of the
third stage labour were compared between cases and controls.
Conditional logistic regression was used to adjust for confounding.
Results: The study included 383 cases and 383 controls. Cases had
signiﬁcantly higher mean estimated blood loss than controls.
However, 16.7% of cases who delivered vaginally and 34.1% of
cases who delivered by Caesarean section (CS) had a blood loss of
< 500 mL and < 1000 mL, respectively; 8.2% of controls who
delivered vaginally and 6.7% of controls who delivered by CS had
blood loss consistent with a diagnosis of postpartum hemorrhage.
Factors associated with atonic postpartum hemorrhage included
known protective factors (e.g., delivery by CS) and risk factors (e.g.,
nulliparity, vaginal birth after CS). Uterotonic use was more commonKey Words: Postpartum hemorrhage, blood loss, risk factors, third
stage
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http://dx.doi.org/10.1016/j.jogc.2016.06.014in cases than in controls (97.6% vs. 92.9%, P < 0.001). Delayed
cord clamping was only used among those who delivered vaginally
(7.7% cases vs. 14.6% controls, P ¼ 0.06).
Conclusion: There is substantial misclassiﬁcation in the diagnosis of
atonic postpartum hemorrhage, and this could potentially explain
the observed temporal increase in postpartum hemorrhage rates.
Résumé
Objectif : Au cours des dernières années, le taux d’hémorragies de la
délivrance par atonie utérine a augmenté dans de nombreux pays
industrialisés. Nous avons examiné les pertes sanguines, les
facteurs de risque et la prise en charge du troisième stade du travail
associés à ce type d’hémorragies.
Méthodologie : Nous avons mené une étude cas-témoins auprès de
patientes de huit hôpitaux de soins tertiaires canadiens, entre
janvier 2011 et décembre 2013. Nous avons étudié des femmes
ayant reçu un diagnostic d’hémorragie de la délivrance par atonie
utérine (cas); nous avons apparié les témoins (sans hémorragie)
aux cas selon l’hôpital visité et la date d’accouchement. Nous avons
comparé les pertes sanguines estimées, les facteurs de risque et la
prise en charge du troisième stade du travail des deux groupes.
Enﬁn, nous avons utilisé la régression logistique conditionnelle pour
tenir compte des variables parasites.
Résultats : L’échantillon à l’étude comprenait 383 cas et 383 témoins.
Les pertes sanguines moyennes estimées du premier groupe
étaient signiﬁcativement supérieures à celles du deuxième.
Cependant, 16,7 % des cas qui ont accouché par voie vaginale et
34,1 % des cas qui ont accouché par césarienne ont perdu moins
de 500 et 1000 ml de sang, respectivement, tandis que 8,2 % des
témoins qui ont accouché par voie vaginale et 6,7 % des témoins
qui ont accouché par césarienne ont perdu une quantité de sang
correspondant à un diagnostic d’hémorragie de la délivrance. LesDECEMBER JOGC DÉCEMBRE 2016 l 1081
OBSTETRICSfacteurs associés à l’hémorragie de la délivrance par atonie utérine
comportaient des facteurs de protection connus (p. ex.
accouchement par césarienne) et des facteurs de risque (p. ex.
nulliparité, accouchement vaginal après une césarienne).
L’administration d’utérotoniques était plus fréquente chez les cas
que chez les témoins (97,6 % contre 92,9 %; P < 0,001), et le
clampage tardif du cordon a seulement été réalisé chez des
femmes qui ont accouché par voie vaginale (7,7 % pour les cas
contre 14,6 % pour les témoins; P ¼ 0,06).
Conclusion : La classiﬁcation du diagnostic de l’hémorragie de la
délivrance par atonie utérine est souvent erronée, ce qui pourrait
expliquer la hausse observée du taux d’hémorragies de la
délivrance.
ª 2016 The Authors. Published by Elsevier Inc. on behalf of The
Society of Obstetricians and Gynaecologists of Canada/La Société des
obstétriciens et gynécologues du Canada. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
J Obstet Gynaecol Can 2016;38(12):1081e1090INTRODUCTION
ostpartum hemorrhage, a major cause of maternalPmorbidity and mortality worldwide, is reported to have
increased in frequency and severity in several industrialized
countries.1e12 Rising rates of postpartum hemorrhage
were ﬁrst reported from Australia (where rates increased
from 4.7 per 100 deliveries in 1994 to 6.0 in 2002)1,2 and
Canada (where rates increased from 4.1 per 100 deliveries
in 1991 to 5.1 in 20043 and 6.2 in 2010).11 Other indus-
trialized countries have also shown similar temporal
increases4e12; in the United States, postpartum hemor-
rhage rates increased from 2.1 per 100 deliveries in 1994 to
2.9 per 100 deliveries in 2006,6 and rates of severe post-
partum hemorrhage rose from 1.9 per 1000 deliveries in
1999 to 4.2 per 1000 deliveries in 2008.4
Although studies have identiﬁed the aforementioned
increase in postpartum hemorrhage as having occurred
mainly because of an increase in atonic postpartum hem-
orrhage,3,5,11,12 the reasons behind this rising trend have not
been adequately explained. Temporal changes in risk factors
such as advanced maternal age, obesity, multi-fetal preg-
nancy, induction of labour, and delivery by CS do not
explain the temporal rise in postpartum hemorrhage.2e12
Similarly, studies examining medication use in pregnancy
have not implicated drug use as contributing signiﬁcantly to
the rising rates of postpartum hemorrhage.13e15 Although
antidepressants, including selective serotonin reuptake in-
hibitors, appear to modestly increase rates of postpartum
hemorrhage,14e16 the relatively low population-attributable
fraction for selective serotonin reuptake inhibitor use
among pregnant women means that such drug use does not
explain the temporal trends in postpartum hemorrhage.141082 l DECEMBER JOGC DÉCEMBRE 2016One hypothesis regarding the increase in atonic post-
partum hemorrhage that has not been investigated relates
to the management of the third stage of labour. Active
management of the third stage of labour includes a package
of interventions, including the following: administration of
a uterotonic agent (oxytocin and/or ergometrine), umbili-
cal cord clamping and cutting, and controlled cord traction,
with uterine massage sometimes included as an additional
component.17e24 However, a lack of consensus on the
efﬁcacy of each component of such active management
means that these interventions are used variably in clinical
practice.25
Most of the epidemiologic studies that have investigated
the temporal increase in postpartum hemorrhage have
used data from large perinatal databases.2e16 Such data
lack detailed clinical information on the active management
of labour, and previous studies have also not adequately
examined issues related to estimated blood loss, obstetric
history, and related factors. We therefore carried out a
multicentre medical chart abstraction study to determine
the estimated blood loss associated with atonic postpartum
hemorrhage and to quantify the association between risk
factors (including obstetric history, medication use, and
management of the third stage of labour) and atonic
postpartum hemorrhage.METHODS
We conducted a case-control study of women who deliv-
ered between January 2011 and December 2013 in eight
tertiary hospitals in Canada, with cases of atonic post-
partum hemorrhage selected from each hospital and con-
trols sampled from the catchment population of the same
hospitals (secondary base26). We deﬁned cases as women
with a diagnosis of atonic postpartum hemorrhage (ICD-
10 code 0721) selected from hospital discharge records.
Controls were matched to cases for hospital and date of
delivery (± 3 days) and included women without any
diagnosis of postpartum hemorrhage (i.e., women without
a diagnosis of atonic or other postpartum hemorrhage).
Information about maternal characteristics, obstetric his-
tory, pregnancy, labour, and delivery was abstracted from
the medical charts of cases and controls. Trained medical
record abstractors used standard forms to enter data into
customized software (RedCap; Research Electronic Data
Capture27). The data collection software was programmed
to restrict entry of implausible values to enhance accuracy
of collected data, and interim analyses were performed to
detect discrepant values that were then corrected by
reference to the original medical charts.
Atonic Postpartum Hemorrhage: Blood Loss, Risk Factors, and Third Stage ManagementThe timing and amount of estimated blood loss for cases
and controls were obtained from the charts. The diagnosis
of atonic postpartum hemorrhage was predominantly
based on the estimated amount of blood loss, including
blood clots and additional characteristics of bleeding. The
deﬁnition of postpartum hemorrhage (as used across
Canada) was  500 mL of blood loss following a vaginal
delivery and  1000 mL blood loss following a CS.
Because the blood loss criteria for postpartum hemor-
rhage differ following vaginal delivery and CS, analyses
were stratiﬁed by mode of delivery, and we identiﬁed
characteristics of women who appeared to have “false
positive” and “false negative” diagnoses of atonic post-
partum hemorrhage based on blood loss criteria alone.
Crude and adjusted ORs (aORs) and 95% CIs expressing
the effects of risk and protective factors on atonic post-
partum hemorrhage were estimated using conditional lo-
gistic regression. We used ICD-10 code-identiﬁed cases of
atonic postpartum hemorrhage and not the estimated
blood loss criteria because the physician’s judgement was
the ﬁnal criterion for a diagnosis of postpartum hemor-
rhage. Three stages of sequential conditional logistic
regression modelling were used to identify independent
risk factors for atonic postpartum hemorrhage. In the ﬁrst
stage, maternal characteristics and obstetric history were
included in the model. In second stage modelling, preg-
nancy characteristics, complications, and interventions
(including medications) were introduced in the model
together with pre-pregnancy risk factors independently
associated with postpartum hemorrhage (identiﬁed in ﬁrst
stage modelling). The last stage of the modelling involved
the addition of interventions during labour and delivery
(including medications). Stepwise backward selection of
statistically signiﬁcant variables (P < 0.05) was used at
each stage, and the ﬁnal model included all signiﬁcant
variables and interaction terms. Medication use during
pregnancy, during hospitalization for delivery, and during
labour was categorised into the following broad groups:
analgesics, anti-asthma agents, anti-hypertensive drugs,
antibiotics, antidepressants, thyroid medication, vitamins,
and herbal supplements. Lastly, the effect of each
component of management of the third stage of labour
was assessed, including timing and dose of oxytocin, use
of other uterotonic medications and other means to
control bleeding, controlled cord traction, and timing of
cord clamping.
Sensitivity analyses were performed after excluding cases
and controls among whom the diagnosis of atonic post-
partum hemorrhage (or its lack thereof) was contradicted
by the estimated blood loss recorded in the medical chart
(i.e., cases with estimated blood loss < 500 mL and< 1000 mL among women with vaginal delivery and de-
livery by CS, respectively), and controls with estimated
blood loss exceeding these cut-offs were excluded. Con-
ditional logistic regression analysis was carried out after
these exclusions to re-identify risk factors for atonic
postpartum hemorrhage. Analyses were carried out using
SAS version 9.3 (SAS Institute Inc., Cary, NC).
Ethics approval was obtained from the Research Ethics
Board of the University of British Columbia and from each
participating site.
RESULTS
Eight participating centres collected data on 393 cases of
atonic postpartum hemorrhage and 393 controls without
postpartum hemorrhage. After excluding pairs with
incomplete data, 383 matched pairs (766 women) were
included in the study. Of these, 296 cases and 272 controls
delivered vaginally, whereas 87 cases and 111 controls
delivered by CS.
Estimated Blood Loss
Blood loss was signiﬁcantly greater in cases with atonic
postpartum hemorrhage than in controls without post-
partum hemorrhage (Table 1). Blood loss  2000 mL was
reported in 2.1% of cases with a vaginal delivery and 3.5%
of cases with delivery by CS. A sizeable proportion of
women had a borderline level of estimated blood loss for a
diagnosis of postpartum hemorrhage; that is, 14.6% of
cases who delivered vaginally had an estimated blood loss
of exactly 500 mL, and 23.0% of cases who delivered by
CS had a blood loss of exactly 1000 mL.
Among women who delivered vaginally, 16.7% of cases
had a blood loss of < 500 mL, and 8.2% of controls had
an estimated blood loss  500 mL. Similarly, among
women who delivered by CS, 34.1% of cases had an esti-
mated blood loss < 1000 mL, and 6.7% of controls had an
estimated blood loss of  1000 mL (Table 1).
Cases of postpartum hemorrhage with vaginal delivery and
< 500 mL of blood loss noted in the chart (n ¼ 47)
differed from cases with  500 mL blood loss. Such
women were signiﬁcantly less likely to be primigravid and
nulliparous, to receive augmentation with oxytocin, to have
a prolonged second stage of labour (> 2 hours), and to
sustain a third- or fourth-degree perineal tear (P < 0.05 for
each). They were also more likely to be positive for group
B Streptococcus and more likely to have experienced
artiﬁcial rupture of membranes (P < 0.05 for both). Three
of these women received transfusions of packed red cells
because of a low hemoglobin concentration or lowDECEMBER JOGC DÉCEMBRE 2016 l 1083
Table 1. Total estimated blood loss among cases with a diagnosis of atonic postpartum hemorrhage and controls
without a diagnosis of postpartum hemorrhage during delivery hospitalization
Estimated blood loss
Vaginal delivery Caesarean section
Cases Controls
Pa
Cases Controls
Pan (n ¼ 296) % n (n ¼ 272) % n (n ¼ 87) % n (n ¼ 111) %
Blood loss (mL)
< 500 47 16.8 223 91.8 < 0.001 0 0.00 13 12.4 < 0.001
500 41 14.6 18 7.41 4 4.60 14 13.3
501 to 999 124 44.3 2 0.82 26 29.9 71 67.6
1000 36 12.9 0 0.00 20 23.0 6 5.71
1001 to 1999 26 9.29 0 0.00 34 39.1 1 0.95
2000 to 2999 4 1.43 0 0.00 1 1.15 0 0.00
 3000 2 0.71 0 0.00 2 2.30 0 0.00
Missing (blood loss) 16 5.41 29 10.7 0.07 0 0.00 6 5.41 -
Blood clots 26 8.75 3 1.10 0.002 6 6.82 0 0.00 -
Excessive bleeding noted 31 10.4 3 1.10 < 0.001 11 12.5 0 0.00 -
Postpartum hemorrhage was deﬁned as blood loss of  500 mL among women with vaginal delivery and  1000 mL among women delivered by CS.
aP values obtained from conditional logistic regression models. Blood loss was modelled as a continuous variable.
OBSTETRICShematocrit. All except one woman received uterotonics,
one woman had balloon tamponade of the uterus, and one
had vaginal packing. Excessive bleeding was explicitly
mentioned in the medical charts of 12 such cases, and
passage of blood clots was recorded for 10 women. Two
women with missing values for blood loss received packed
red cell transfusions for low hemoglobin concentration or
low hematocrit. Among controls who delivered vaginally
and experienced a blood loss of  500 mL (n ¼ 20), 18
had an estimated blood loss of exactly 500 mL, and two
had an estimated blood loss of 600 mL. No procedures to
control bleeding were used in these women, although they
received signiﬁcantly higher doses of oxytocin.
Cases who delivered by CS and lost < 1000 mL of blood
during delivery (n ¼ 30) were not signiﬁcantly different
from cases who lost  1000 mL following CS (P > 0.05).
Six of the former received packed red cells for a low he-
moglobin concentration or low hematocrit. Excessive
bleeding was mentioned in the charts of eight of these
women (26.7%) and passage of blood clots in ﬁve (16.7%).
Risk Factors for Postpartum Hemorrhage
The unadjusted associations between maternal character-
istics, obstetric history, pregnancy complications, and
atonic postpartum hemorrhage are shown in Table 2, and
associations between labour and delivery characteristics
and atonic postpartum hemorrhage are shown in Table 3.
Details of medication use are provided in Appendix
Table A1.
Conditional logistic regression showed that multiparity, one
or two previous abortions, and smoking were associated1084 l DECEMBER JOGC DÉCEMBRE 2016with lower odds of atonic postpartum hemorrhage
(Table 4, model stage 1). Previous CS was associated with
an increased rate of atonic postpartum hemorrhage in
women who subsequently delivered vaginally (aOR 3.88;
95% CI 1.24 to 12.20) compared with women without
previous CS who delivered vaginally.
Additional adjustment for pregnancy factors (Table 4,
model stage 2) showed that use of vitamins and analgesics
during pregnancy, preeclampsia, and use of magnesium
sulfate were associated with atonic postpartum hemor-
rhage. Adjustment for labour and delivery factors (Table 4,
model stage 3) showed that induction of labour with
oxytocin, artiﬁcial rupture of membranes, intrapartum fe-
ver, forceps delivery, and antibiotic use during delivery
increased the odds of atonic postpartum hemorrhage.
Vaginal birth after CS increased the odds of postpartum
hemorrhage (aOR ¼ 3.70; 95% CI 1.08 to 12.71), whereas
primary and repeat CS lowered the odds (aOR ¼ 0.53;
95% CI 0.32 to 0.88, and aOR ¼ 0.47; 95% CI 0.24 to
0.95, respectively) compared with vaginal delivery among
women without a prior CS. Rare risk factors for atonic
postpartum hemorrhage, including placenta accreta,
chronic hypertension, and some medication use, could not
be included in modelling due to their small numbers or
strong correlation with other variables (collinearity).
Sensitivity analysis using conditional logistic regression was
performed after exclusion of cases and controls with a
diagnosis of postpartum hemorrhage that was contradicted
by the estimated blood loss recorded in the medical chart.
Most results did not change appreciably, but the aOR for
delivery by CS in women without prior CS compared with
Table 2. Unadjusted associations between maternal
characteristics, obstetric history, pregnancy
characteristics, and atonic postpartum hemorrhage
Demographic characteristics
and obstetric history
Case Control
Pan ¼ 383 % n ¼ 383 %
Maternal age (years) 0.07
< 20 18 4.70 7 1.84
20 to 24 44 11.49 36 9.45
25 to 29 100 26.11 96 25.20
30 to 34 122 31.85 138 36.22
35 to 39 73 19.06 82 21.52
 40 26 6.79 22 5.77
Gravida
1 (primigravida) 190 49.74 104 27.37 ref.
2 to 3 135 35.34 212 55.79 < 0.001
 4 57 14.92 64 16.84 0.002
Parity
0 238 62.80 160 42.44 ref.
1 to 2 125 32.98 191 50.66 < 0.001
 3 16 4.22 26 6.90 0.01
Prior abortion(s) 106 27.97 138 36.60 0.01
Iatrogenic 37 9.76 47 12.47 0.24
Spontaneous 65 17.15 82 21.75 0.11
Current smoker 32 8.63 56 15.14 0.007
Drug use 1 0.27 2 0.54 0.57
Previous CS 36 9.50 52 13.98 0.08
Uterine ﬁbroids 8 2.09 5 1.31 0.41
Prior uterine surgery 29 7.57 33 8.62 0.57
Chronic hypertension 6 1.57 0 0.00 -
Diabetes mellitus 5 1.31 3 0.78 0.48
Pregnancy characteristics
and interventions
Case Control
Pan ¼ 383 % n ¼ 383 %
Hypertension during
pregnancy
19 4.96 12 3.13 0.20
Preeclampsia 27 7.05 4 1.04 < 0.001
Gestational diabetes
mellitus
26 7.05 23 6.17 0.65
Polyhydramnios 6 1.57 3 0.79 0.33
Chorioamnionitis 16 4.28 6 1.58 0.03
PROM 55 14.44 49 12.86 0.52
PROM for  24 hours 18 4.76 11 2.87 0.17
Suspected large fetus 13 3.4 7 1.83 0.16
Multiple pregnancy 15 3.92 8 2.09 0.13
Maternal infection 60 15.79 51 13.46 0.33
GBS positive 26 6.79 23 6.01 0.66
Continued
Table 2.Continued
Pregnancy characteristics
and interventions
Case Control
Pan ¼ 383 % n ¼ 383 %
Male fetus 194 50.79 184 48.04 0.45
Magnesium sulfate (any) 14 3.66 1 0.26 0.01
Multiple doses 9 2.35 1 0.26 0.04
Preeclampsia indication 7 1.83 1 0.26 0.07
Neuroprotectionb 7 1.83 0 0.00 -
Tocolytic 6 1.57 0 0.00 -
PROM: premature rupture of membranes; GBS: group B Streptococcus.
NOTE: Missing values < 4% not shown; 24 (3.1%) women had missing values
for gestational diabetes mellitus; no CSs among women with multiple
pregnancies and vaginal delivery.
aP values obtained from conditional logistic regression models. Maternal age
was modelled as a continuous variable.
bOne indication was for low magnesium blood level (case).
Atonic Postpartum Hemorrhage: Blood Loss, Risk Factors, and Third Stage Managementvaginal delivery in women without prior CS decreased
(aOR ¼ 0.16; 95% CI 0.06 to 0.46), and the aOR for
artiﬁcial rupture of membranes also decreased (aOR ¼
2.23; 95% CI 0.93 to 5.37).Procedures to Control Bleeding
Uterotonics were used extensively during the third stage of
labour and to control postpartum hemorrhage (Appendix
Table A2). Uterotonic use was signiﬁcantly more com-
mon in cases with atonic postpartum hemorrhage than in
controls without postpartum hemorrhage (97.6% vs.
92.9%, P ¼ 0.003). Oxytocin was the most common
uterotonic used, followed by prostaglandins and ergome-
trine. Blood transfusions were administered in 12.5% of
cases (8.8% of cases who delivered vaginally and 25.3%
of cases who delivered by CS). Atonic postpartum
hemorrhage was associated with higher doses of oxytocin
(P < 0.001; Appendix Table A3).
Management of the Third Stage of Labour
Information about management of the third stage of la-
bour was incomplete in charts from most study sites. Data
from three hospitals with < 10% missing values for
controlled cord traction (n ¼ 271) revealed no signiﬁcant
differences between cases with atonic postpartum hemor-
rhage and controls (30.1% of cases had controlled cord
traction compared with 25.4% of controls, P ¼ 0.40),
irrespective of mode of delivery. Assessment of cord
clamping (in four hospitals with a low proportion of
missing values) showed that none of the women who
delivered by CS (n ¼ 102) had delayed cord clamping, and
delayed cord clamping was non-signiﬁcantly protective
against atonic postpartum hemorrhage among women who
delivered vaginally (7.7% vs. 14.6%, P ¼ 0.06).
DISCUSSION
Our study showed a signiﬁcant disagreement between the
diagnosis of atonic postpartum hemorrhage and the volume
of postpartum blood loss as documented in the medicalDECEMBER JOGC DÉCEMBRE 2016 l 1085
Table 3. Unadjusted associations between labour and
delivery characteristics and atonic postpartum
hemorrhage
Labour and delivery
characteristics
Case Control
Pan ¼ 383 % n ¼ 383 %
CS 87 22.72 111 28.98 0.065
No labour 33 8.62 60 16.67 0.003
Spontaneous onset of
labour
178 46.6 213 55.61 0.01
Labour inductionb 170 44.5 109 28.46 < 0.001
Oxytocin 122 31.94 73 19.16 < 0.001
Prostaglandin 64 16.84 42 10.99 0.02
ManualdFoley
catheter
10 2.61 8 2.09 0.64
Manualdsweep of
membranes
4 1.04 3 0.78 0.71
ManualdARM 46 12.01 18 4.70 0.02
Failed induction 26 6.82 17 4.47 0.19
Labour augmentation 130 33.94 101 26.44 0.02
Oxytocin augmentation 126 33.07 93 24.80 0.01
Epidural analgesia 277 73.87 224 60.70 < 0.001
Spinal analgesia 34 9.14 67 18.21 < 0.001
General anaesthesia 14 3.73 8 2.17 0.26
Analgesia medication
during labourc
180 47 152 39.90 0.03
Antiemetic use 124 33.33 109 28.61 0.14
Thromboprophylaxis
(any)
20 5.26 23 6.04 0.68
Thromboprophylaxis
with heparin
16 4.21 20 5.25 0.54
Placenta previa 8 2.09 1 0.26 0.05
Placental abruption 3 0.79 2 0.52 0.66
Placenta accreta 2 0.52 0 0.00 -
Presentation 0.74
Cephalic 358 96.5 351 95.38
Breech 8 2.16 16 4.08
Transverse 4 1.08 1 0.27
Compound 0 0 1 0.27
Oblique 1 0.27 0 0.00
Prolonged second stage
(> 2 hours)
82 22.84 39 10.96 < 0.001
Intrapartum fever 29 7.61 6 1.59 < 0.001
Emergency CS 66 17.23 57 14.88 0.40
Assisted vaginal delivery 74 25.87 37 14.29 < 0.001
Low forceps 23 6.01 9 2.35 0.01
Mid-pelvic forceps 13 3.39 3 0.78 0.02
Vacuum assisted 31 8.09 24 6.27 0.33
Gestational age (weeks) 0.40
< 28 5 1.31 1 0.26
28 to 31 4 1.04 2 0.52
32 to 36 26 6.79 26 6.79
Continued
Table 3.Continued
Labour and delivery
characteristics
Case Control
Pan ¼ 383 % n ¼ 383 %
37 to 41 346 90.34 354 92.43
 42 2 0.52 0 0.00
Lacerations 29 7.92 13 3.48 0.01
Perineal tear (third or
fourth grade)
24 6.52 12 3.20 0.05
Cervical laceration 5 1.31 2 0.52 0.22
Uterine rupture 0 0 0 0.00 -
Macrosomic baby
(> 4500 g)
16 4.21 6 1.60 0.04
ARM: artiﬁcial rupture of membranes.
NOTE: Male fetus, presentation, and macrosomia relate to twin A in multiple
pregnancies; multiple pregnancy includes one set of triplets (delivery by CS); all
multiples were delivered by one mode of delivery (either vaginal or CS); missing
values < 2% not shown: 28 (3.6%) women had a missing value for presentation,
3.1% women had a missing value for perineal tear, and 3.0% of women had a
missing value for the type of assisted vaginal delivery.
aP values obtained from conditional logistic regression models; presentation
cephalic compared with other, preterm gestational age compared with term.
bTypes of induction can overlap.
cIncludes morphine, fentanyl, meperidine, butorphanol, nalbuphine, nitrous
oxide.
1086 l DECEMBER JOGC DÉCEMBRE 2016
OBSTETRICSchart. This discrepancy reﬂects the difﬁculty of estimating
blood loss during childbirth and highlights the uncertain
nature of a diagnosis of postpartum hemorrhage as docu-
mented routinely in hospital records. Our analysis of risk
factors for atonic postpartum hemorrhage yielded results
essentially consistent with the literature. Vaginal delivery
after CS increased the odds, whereas repeat delivery by CS
decreased the odds of atonic postpartum hemorrhage
comparedwith vaginal delivery without prior CS. Finally, our
examination of components of the third stage of labour was
hampered by poor documentation (with the exception of
uterotonic use, which was well-documented and uniformly
high), although ﬁndings from study sites that had good
documentation were consistent with expectations.
The deﬁnition of postpartum hemorrhage varies between
countries.5 In the United States and Canada, postpartum
hemorrhage is deﬁned as a blood loss of  500 mL
following vaginal delivery and  1000 mL following CS.3,17
The deﬁnition of postpartum hemorrhage in the United
Kingdom speciﬁes a blood loss of  500 mL,28 whereas in
Australia postpartum hemorrhage is diagnosed if blood
loss is  500 mL following vaginal delivery and  750 mL
following CS.5 Our study showed that the diagnosis of
postpartum hemorrhage was not consistent with stipulated
blood loss criteria in a signiﬁcant proportion of instances.
In addition, a large proportion of diagnoses of postpartum
hemorrhage had blood loss amounts that corresponded to
Table 4. Results of conditional logistic regression with sequential modelling of risk factors for atonic postpartum
hemorrhage
Risk factor
Unadjusted Stage 1a Stage 2b Stage 3c
OR 95% CI aOR 95% CI aOR 95% CI aOR 95% CI
Demographics/obstetric history
Parity 0 ref. ref. ref. ref.
 1 0.44 (0.33 to 0.60) 0.41 (0.29 to 0.58) 0.50 (0.35 to 0.70) 0.47 (0.24 to 0.95)
Previous abortions 0 ref. ref.
1 to 2 0.62 (0.44 to 0.88) 0.66 (0.45 to 0.97) 0.58 (0.39 to 0.85) 0.62 (0.40 to 0.94)
 3 1.04 (0.46 to 2.34) 1.50 (0.61 to 3.67) 1.55 (0.62 to 3.87) 1.21 (0.47 to 3.15)
Smoking during pregnancy 0.53 (0.33 to 0.84) 0.58 (0.35 to 0.95)
Vaginal delivery without prior CS ref. ref. ref. ref.
Vaginal delivery with prior CS 3.07 (1.00 to 9.43) 3.88 (1.24 to 12.2) 3.42 (1.07 to 11.0) 3.70 (1.08 to 12.7)
CS without prior CS 0.98 (0.68 to 1.43) 0.81 (0.53 to 1.24) 0.73 (0.48 to 1.12) 0.53 (0.32 to 0.88)
CS with prior CS 0.43 (0.24 to 0.74) 0.66 (0.36 to 1.22) 0.56 (0.30 to 1.03) 0.47 (0.24 to 0.95)
Pregnancy characteristics
Magnesium sulfate 14.0 (1.8 to 106.4) 10.8 (1.24 to 94.6) 10.8 (1.19 to 98.8)
Preeclampsia 6.75 (2.36 to 19.3) 7.21 (2.23 to 23.3) 6.25 (1.77 to 22.1)
Analgesic medication (during
pregnancy)
0.58 (0.30 to 1.13) 0.45 (0.20 to 0.98)
Vitamin use (during pregnancy) 1.66 (1.10 to 2.50) 1.70 (1.06 to 2.71) 1.84 (1.12 to 3.02)
Labour and delivery characteristics
Labour induction with oxytocin 2.09 (1.46 to 2.98) 1.62 (1.05 to 2.51)
Artiﬁcial rupture of membranes 3.18 (1.72 to 5.87) 2.50 (1.22 to 5.14)
Forceps delivery 3.56 (1.76 to 7.23) 2.38 (1.04 to 5.45)
Intrapartum fever 5.75 (2.22 to 14.9) 5.26 (1.75 to 15.7)
Antibiotic use (during delivery) 1.31 (0.98 to 1.75) 1.56 (1.04 to 2.35)
NOTE: Factors not signiﬁcantly associated with postpartum hemorrhage in the logistic regression included the following:
aMaternal age (< 25, 25 to 34,  35 years); drug use; uterine ﬁbroids; uterine surgery; chronic hypertension; and diabetes mellitus.
bHypertension during pregnancy; gestational diabetes; polyhydramnios; chorioamnionitis; preterm premature rupture of membranes (none, < 24 hours,  24 hours);
suspected large fetus; multiple pregnancy; maternal infection; Streptococcus B positive culture; antidepressants; thyroid drugs; acute asthma drug; chronic asthma
drugs; antibiotics; herbal medicine use during pregnancy.
cAbsence of labour; spontaneous onset of labour; labour induction by sweep of membranes; labour induction by Foley catheter; failed induction; epidural; spinal
analgesia; general anesthesia; analgesics; antiemetic; thromboprohylaxis; placenta previa; placental abruption; cephalic position (compared with other); prolonged
second stage (> 2 hours); emergency CS; forceps delivery; vacuum delivery; gestational age (< 34, 34 to 36,  37 weeks); laceration (third- to fourth-degree tear or
high cervical laceration compared with none of these); macrosomic baby (> 4500 g); antidepressants; antibiotics; thyroid drugs; acute asthma drug; vitamin use during
pregnancy hospitalization; antidepressants; thyroid drugs; vitamins; and herbal medicine during delivery. Placenta accreta and thyroid drugs during delivery were not
included due to collinearity.
Atonic Postpartum Hemorrhage: Blood Loss, Risk Factors, and Third Stage Managementthe threshold blood loss values (500 mL and 1000 mL) for
postpartum hemorrhage, suggesting that there were chal-
lenges in estimating blood loss and rounding of blood loss
estimates. Also noteworthy was the ﬁnding that 67.8% of
controls with delivery by CS had an estimated blood loss of
501 mL to 999 mL, which would have led to a diagnosis of
postpartum hemorrhage if these controls had delivered
vaginally (or if these deliveries had occurred in the United
Kingdom).
Our ﬁndings contrast with a report from Australia in
which chart-recorded diagnoses underestimated the fre-
quency of postpartum hemorrhage according to the
amount of blood loss.25,29 Our study also highlighted some
discrepancies between estimated blood loss and the
documentation of blood clots and excessive bleeding.These ﬁndings point to subjective diagnoses and/or
incomplete documentation in medical charts. Routine vi-
sual estimates of blood loss are known to be inaccu-
rate,29,30 and temporal trends in postpartum hemorrhage
may have been inﬂuenced by caregiver changes in aware-
ness or heightened concern about excessive bleeding. Such
misclassiﬁcation of atonic postpartum hemorrhage may
potentially explain the temporal increase in postpartum
hemorrhage rates reported from several countries.1e12
However, such a diagnostic change cannot explain the
temporal increase in severe postpartum hemorrhage
(i.e., postpartum hemorrhage associated with transfusion
and operative procedures to control bleeding) also
observed in several countries.1e12 On the other hand, both
the increase in postpartum hemorrhage and in severeDECEMBER JOGC DÉCEMBRE 2016 l 1087
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quence of the gradual shift towards a culture of safety that
has characterized obstetrics in recent years. The subjectivity
involved in making a diagnosis of postpartum hemorrhage
may have been affected by heterogeneity in maternal re-
sponses to blood loss; clinical signs of postpartum hem-
orrhage may be more pronounced among women with
mild anemia.
Our study ﬁndings are in general agreement with the
literature on risk factors for atonic postpartum hemor-
rhage. However, the associations between one and two
previous abortions, vitamin and analgesic use, and atonic
postpartum hemorrhage were unexpected and should be
treated as preliminary and requiring conﬁrmation in other
studies. It is possible that previous pregnancies, ending in
either childbirth or abortion, induce hormonal and other
uterine changes that reduce the risk of postpartum hem-
orrhage.31 The lower risk of postpartum hemorrhage
following a CS has been observed previously,2,12 although
some studies have reported the opposite effect.4,9e11 The
conﬂicting ﬁndings are likely due to the different deﬁni-
tions of postpartum hemorrhage following vaginal delivery
and CS used in different studies. Another signiﬁcant
consideration is the effect of previous CS. Our study
showed that delivery by CS modiﬁes the effect of previous
CS; women with a previous CS who subsequently delivered
vaginally had a higher rate of postpartum hemorrhage than
women who did not have a previous CS, whereas women
with a previous CS who delivered again by CS had
signiﬁcantly lower rates of atonic postpartum hemorrhage.
Our study showed a strong association between pre-
eclampsia and postpartum hemorrhage, a ﬁnding consistent
with the literature.2,4,9,12 We also observed a strong associ-
ation between use of magnesium sulfate and postpartum
hemorrhage. Magnesium sulfate treatment is indicated for
severe preeclampsia/eclampsia, which may in part explain
the association with postpartum hemorrhage. However,
approximately one half of the women in our study received
magnesium sulfate for fetal neuroprotection. We could not
examine these two indications separately due to small
numbers, and magnesium sulfate was not included in the
ﬁnal regression model because of collinearity. Nevertheless,
the independent effect of magnesium sulfate on postpartum
hemorrhage deserves further scrutiny because the drug is
known to have tocolytic effects32 that may contribute to
uterine atony regardless of indication.
Oxytocin use during the third stage of labour was almost
ubiquitous, with cases receiving higher oxytocin doses.
However, cases of atonic postpartum hemorrhage were1088 l DECEMBER JOGC DÉCEMBRE 2016signiﬁcantly more likely to receive other uterotonics,
including prostaglandins and ergometrine. Transfusions
were more common in cases with delivery by CS than in
those with vaginal delivery because the amount of blood
loss was larger following CS. Besides use of uterotonics,
recent recommendations for active management of the
third stage of labour include delayed cord clamping and
controlled cord traction.20 Even though delayed cord
clamping has been shown to confer signiﬁcant beneﬁts for
the infant (increased birth weight and better hemodynamic
indices), maternal beneﬁts remain unclear.33,34 Controlled
cord traction has been shown to reduce the risk of manual
removal of the placenta and to reduce blood loss of 500
mL or more.20 In our study, approximately 30% of de-
liveries were reported to have controlled cord traction,
although information on controlled cord traction and cord
clamping was poorly documented. In comparison, reports
from Australia show that controlled cord traction was
applied in 30% of deliveries by CS and in 80% of vaginal
deliveries.25
Our study has several strengths, including detailed infor-
mation on cases of atonic postpartum hemorrhage and
controls without postpartum hemorrhage collected
through a standardized protocol from several hospitals in
Canada. In particular, this level of detail describing the
amount of estimated blood loss, type of induction of la-
bour, and timing of medication has not been reported
previously.
Limitations of our study include incomplete data on cord
clamping, controlled cord traction, and uterine massage
from several hospitals due to poor documentation in
medical charts. Secondly, our study had limited statistical
power to detect associations between relatively rare con-
ditions (e.g., placenta previa, polyhydramnios, multifetal
pregnancy, chorioamnionitis) and postpartum hemor-
rhage. Thirdly, our inferences regarding underdiagnoses
and overdiagnoses of atonic postpartum hemorrhage and
use or non-use of interventions were hampered by an
inability to distinguish between poor documentation and
incorrect diagnosis/management. Some inconsistencies
between the diagnosis of atonic postpartum hemorrhage
and estimated blood loss may have been due to the
timing of diagnosis (e.g., made soon after delivery by
physician) and difﬁculty in estimated blood loss due to
hemorrhage occurring subsequently (e.g., small but
persistent blood loss following delivery noted by nurse).
Finally, while we quantiﬁed the effects of prior CS on
women delivering vaginally and by CS, we did not include
all the indications for CS in the regression model to avoid
complexity.
Atonic Postpartum Hemorrhage: Blood Loss, Risk Factors, and Third Stage ManagementCONCLUSION
Our study shows that the diagnosis of atonic postpartum
hemorrhage is prone to signiﬁcant misclassiﬁcation
because there are signiﬁcant inconsistencies between blood
loss and the diagnosis as documented in the medical chart.
Population trends in postpartum hemorrhage may have
been potentially inﬂuenced by secular changes in health
care provider concerns about blood loss. Although our
study shows low adherence to speciﬁc components of
active management of the third stage of labour (such as
controlled cord traction), we were unable to determine
whether this was a consequence of poor documentation or
due to the lack of use of such interventions. Careful
adherence to proven strategies for managing the third stage
of labour and improved documentation will help address
concerns associated with the recent temporal increases in
postpartum hemorrhage that have been reported in several
industrialized countries.
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Appendix Table A1. Medication use during pregnancy and in the delivery hospitalization among cases with atonic
postpartum hemorrhage and controls without postpartum hemorrhage
Medication
Case Control
P Examplesn ¼ 383 % n ¼ 383 %
Analgesic medication 77 20.26 59 15.53 0.07
During pregnancy 16 4.21 26 6.84 0.11 ibuprofen, acetylsalicylic acid, acetaminophen, lorazepam,
acetaminophenþcodeineþcaffeine
During delivery hospitalization 31 8.68 17 4.47 0.03
During delivery 33 8.68 17 4.47 0.02
Acute antiasthmatics 9 2.36 7 1.83 0.62 albuterol, terbutaline, epinephrine, hydrocortisone,
isoetharine
During pregnancy 8 2.1 7 1.83 0.79
Chronic antiasthmatics 9 2.36 7 1.85 0.62 albuterol, beclomethasone, budesonide
Antihypertensives 19 5 12 3.15 0.19 furosemide, hydralazine, hydrochlorothiazide, labetalol,
methyldopa, nifedipine, verapamil
During pregnancy 8 2.11 8 2.11 1.00
During delivery hospitalization 6 1.58 2 0.52 0.18
During delivery 8 2.11 7 1.84 0.79
Antibiotics 180 47.24 161 42.37 0.18 amoxicillin, ampicillin, cefazolin, ceftazidime, ceftriaxone,
ciproﬂoxacin, clindamycin, gentamicin, penicillin G,
streptomycin, vancomycin, trimethoprim
During pregnancy 13 3.41 16 4.21 0.58
During delivery hospitalization 30 7.87 22 5.79 0.23
During delivery 157 41.21 131 34.47 0.07
Antidepressants 11 2.89 5 1.31 0.16 amytriptyline, bupropion, citalopram, doxepin, duloxetine,
ﬂuoxetine, haloperidol, imipramine, nefazodone,
paroxetine, sertraline, trimimpramine
During pregnancy 11 2.87 8 2.08 0.53
During delivery hospitalization 1 0.26 0 0.00 -
During delivery 1 0.26 1 0.26 -
Thyroid medication 17 4.5 11 2.87 0.22 thyroxine
During pregnancy 17 4.5 11 2.87 0.22
During delivery hospitalization 2 0.53 1 0.26 0.57
During delivery 2 0.53 1 0.26 0.57
Vitamins 220 57.89 199 52.51 0.03 Materna (prenatal multivitamin)
During pregnancy 214 56.32 190 50.13 0.02
During delivery hospitalization 6 1.58 2 0.53 0.18
During delivery 5 1.32 4 1.06 0.48
Herbal supplements 5 1.31 4 1.05 0.74 herbal teas, homeopathic medication
NOTE: P values obtained from conditional logistic regression models.
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Appendix Table A2. Procedures to control bleeding among cases with atonic postpartum hemorrhage and controls
without postpartum hemorrhage
Procedures to control bleeding
Case Control
Pan ¼ 383 % n ¼ 383 %
Uterotonics (any) 374 97.65 356 92.95 0.003
Oxytocin use 364 95.04 344 89.82 0.008
Prostaglandin use 179 46.74 11 2.87 < 0.001
Carboprost 85 22.19 1 0.26 < 0.001
Other (misoprostol) 145 37.86 10 2.61 < 0.001
Ergometrine use 23 6.01 0 0.00 -
Other medicationsb 17 4.44 12 3.13 0.34
Vaginal packing 10 2.61 0 0.00 -
Uterine packing 1 0.26 0 0.00 -
B-Lynch suture 6 1.57 0 0.00 -
Balloon catheter 22 5.74 0 0.00 -
Embolization of uterine arteries 2 0.52 0 0.00 -
Hysterectomy to control bleeding 4 1.04 0 0.00 -
Transfusion (blood products) 48 12.53 0 0.00 -
NOTE: Percentages may not add up to 100 due to missing values; missing values < 2% not shown.
aP values obtained from conditional logistic regression models.
bIncludes carbetocin and tranexamic acid.
Appendix Table A3. Oxytocin doses during the third stage of labour among postpartum hemorrhage cases and controls
Oxytocin doses (units)
Vaginal delivery CS
Cases Controls Cases Controls
n ¼ 296 % n ¼ 272 % n ¼ 87 % n ¼ 111 %
None 6 2.04 25 9.33 13 15.5 14 12.8
1 to 10 46 15.6 110 41.0 13 15.5 7 6.42
11 to 20 44 15.0 58 21.6 14 16.7 46 42.2
21 to 30 61 20.7 55 20.5 8 9.52 16 14.7
31 to 40 58 19.7 10 3.73 10 11.9 5 4.59
41 to 50 47 16.0 4 1.49 6 7.14 16 14.7
51 to 60 9 3.06 2 0.75 5 5.95 2 1.83
61 to 70 11 3.74 2 0.75 4 4.76 2 1.83
71 to 80 8 2.72 2 0.75 3 3.57 0 0.00
81 to 90 1 0.34 0 0.00 1 1.19 0 0.00
91 to 100 1 0.34 0 0.00 2 2.38 1 0.92
100 to 200 2 0.68 0 0.00 5 5.95 0 0.00
NOTE: Conditional logistic regression based P value < 0.001 for differences in oxytocin dose for cases and controls
following vaginal delivery, and P value 0.054 following delivery by CS. Oxytocin dose modelled as a continuous variable.
Missing values: n ¼ 11.
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